![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Completed |
Unique ID issued by UMIN | UMIN000011801 |
Receipt No. | R000013731 |
Scientific Title | Is Goreisan effective for preventing postoperative nausea and vomiting?-The randomized controlled trial- |
Date of disclosure of the study information | 2013/11/30 |
Last modified on | 2018/09/23 |
Basic information | ||
Public title | Is Goreisan effective for preventing postoperative nausea and vomiting?-The randomized controlled trial- | |
Acronym | Is Goreisan effective for preventing postoperative nausea and vomiting? | |
Scientific Title | Is Goreisan effective for preventing postoperative nausea and vomiting?-The randomized controlled trial- | |
Scientific Title:Acronym | Is Goreisan effective for preventing postoperative nausea and vomiting? | |
Region |
|
Condition | |||
Condition | Postoperative Nausea and Vomiting | ||
Classification by specialty |
|
||
Classification by malignancy | Others | ||
Genomic information | NO |
Objectives | |
Narrative objectives1 | To evaluate the effect of Goreisan for postoperative nausea and vomiting with gynecological patients after general anesthesia |
Basic objectives2 | Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase | Not applicable |
Assessment | |
Primary outcomes | The severity of postoperative nausea and vomiting evaluated by objective scaling number.
The total amount of antiemetic drug dosage used for postoperative nausea and vomiting. |
Key secondary outcomes | The severity of postoperative pain evaluated by objective scaling number.
The amount of analgesic drug dosage needed to control patients pain. |
Base | |
Study type | Interventional |
Study design | |
Basic design | Parallel |
Randomization | Randomized |
Randomization unit | Individual |
Blinding | Single blind -investigator(s) and assessor(s) are blinded |
Control | Placebo |
Stratification | NO |
Dynamic allocation | NO |
Institution consideration | Institution is considered as a block. |
Blocking | YES |
Concealment | Central registration |
Intervention | |||
No. of arms | 2 | ||
Purpose of intervention | Prevention | ||
Type of intervention |
|
||
Interventions/Control_1 | Before the surgical operation is completed, we administer Goreisan through a gastric tube.
|
||
Interventions/Control_2 | Before the surgical operation is completed, we administer normal saline through a gastric tube.
|
||
Interventions/Control_3 | |||
Interventions/Control_4 | |||
Interventions/Control_5 | |||
Interventions/Control_6 | |||
Interventions/Control_7 | |||
Interventions/Control_8 | |||
Interventions/Control_9 | |||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Female | |||
Key inclusion criteria | Gynecological elective surgery patients with general anesthesia
|
|||
Key exclusion criteria | Severe preoperative complications
Severe postoperative complications History of the Chinese herb usage History of the chemotherapy for malignnant deseases |
|||
Target sample size | 200 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Tokyo Women's Medical University | ||||||
Division name | Anesthesiology | ||||||
Zip code | |||||||
Address | Tokyo, Japan 162-8666 | ||||||
TEL | 03-3353-8111 | ||||||
mozaki@anes.twmu.ac.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Tokyo Women's Medical University | ||||||
Division name | Anesthesiology | ||||||
Zip code | |||||||
Address | Tokyo, Japan 162-8666 | ||||||
TEL | 03-3353-8111 | ||||||
Homepage URL | |||||||
kkume@anes.twmu.ac.jp |
Sponsor | |
Institute | Tokyo Women's Medical University
|
Institute | |
Department |
Funding Source | |
Organization | Tokyo Women's Medical University |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions | 東京女子医科大学病院 |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Published |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Completed | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
|
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013731 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |